These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

351 related articles for article (PubMed ID: 36829171)

  • 21. [Metagenomic next-generation sequencing for the diagnosis of Pneumocystis jirovecii pneumonia after allogeneic hematopoietic stem cell transplantation].
    Fu R; Lin R; Fan ZP; Huang F; Xu N; Xuan L; Huang YF; Liu H; Zhao K; Wang ZX; Jiang L; Dai M; Sun J; Liu QF
    Zhonghua Xue Ye Xue Za Zhi; 2024 Jan; 45(1):62-67. PubMed ID: 38527840
    [No Abstract]   [Full Text] [Related]  

  • 22. Metagenomic Next-Generation Sequencing for Accurate Diagnosis of
    Luo W; Lin X; Chen Y; Luo W; Zhang H
    Infect Drug Resist; 2024; 17():2965-2974. PubMed ID: 39045107
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Application of Metagenomic Next-Generation Sequencing to Diagnose Pneumocystis jirovecii Pneumonia in Kidney Transplantation Recipients.
    Xu J; Yu Y; Lv J; Yang S; Wu J; Chen J; Peng W
    Ann Transplant; 2021 Jun; 26():e931059. PubMed ID: 34099614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Alterations of lung microbiota in lung transplant recipients with pneumocystis jirovecii pneumonia.
    Lian Q; Song X; Yang J; Wang L; Xu P; Wang X; Xu X; Yang B; He J; Ju C
    Respir Res; 2024 Mar; 25(1):125. PubMed ID: 38486264
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Veno-Venous Extracorporeal Membrane Oxygenation for Severe Pneumocystis jirovecii Pneumonia in an Immunocompromised Patient without HIV Infection.
    Nureki SI; Usagawa Y; Watanabe E; Takenaka R; Shigemitsu O; Abe T; Yasuda N; Goto K; Kitano T; Kadota JI
    Tohoku J Exp Med; 2020 Apr; 250(4):215-221. PubMed ID: 32249237
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High prevalence and mortality of Pneumocystis jirovecii pneumonia in anti-MDA5 antibody-positive dermatomyositis.
    Chen X; Shu X; He L; Yang H; Lu X; Wang G; Ge Y
    Rheumatology (Oxford); 2023 Oct; 62(10):3302-3309. PubMed ID: 36734589
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characteristics and Prognostic Factors of Non-HIV Immunocompromised Patients With Pneumocystis Pneumonia Diagnosed by Metagenomics Next-Generation Sequencing.
    Duan J; Gao J; Liu Q; Sun M; Liu Y; Tan Y; Xing L
    Front Med (Lausanne); 2022; 9():812698. PubMed ID: 35308503
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The impact of concomitant pulmonary infection on immune dysregulation in Pneumocystis jirovecii pneumonia.
    Chou CW; Lin FC; Tsai HC; Chang SC
    BMC Pulm Med; 2014 Nov; 14():182. PubMed ID: 25409888
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pneumocystis jirovecii pneumonia in AIDS and non-AIDS immunocompromised patients - an update.
    Lee YT; Chuang ML
    J Infect Dev Ctries; 2018 Oct; 12(10):824-834. PubMed ID: 32004150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Pneumocystis jirovecii and quantitative PCR: Pneumonia or colonization?].
    Gazaignes S; Bergeron A; Menotti J; Desseaux K; Molina JM; De Castro N
    Rev Mal Respir; 2020 Apr; 37(4):299-307. PubMed ID: 32273116
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Clinical Value of Metagenomic Next-Generation Sequencing in
    Huang MQ; Zheng TT; Wang XR; Xiang F
    Infect Drug Resist; 2024; 17():69-80. PubMed ID: 38223562
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of CD4 cell count as discriminatory measure to guide chemoprophylaxis against Pneumocystis jirovecii pneumonia in human immunodeficiency virus-negative immunocompromised patients: A systematic review.
    Messiaen PE; Cuyx S; Dejagere T; van der Hilst JC
    Transpl Infect Dis; 2017 Apr; 19(2):. PubMed ID: 28035717
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Metagenomic next-generation sequencing targeted and metagenomic next-generation sequencing for pulmonary infection in HIV-infected and non-HIV-infected individuals.
    Sun L; Zhang K; Liu Y; Che L; Zhang P; Wang B; Du N
    Front Cell Infect Microbiol; 2024; 14():1438982. PubMed ID: 39224706
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Negative serum (1,3) -β-D-glucan has a low power to exclude Pneumocystis jirovecii pneumonia (PJP) in HIV-uninfected patients with positive qPCR.
    Huang Y; Yi J; Song JJ; Du LJ; Li XM; Cheng LL; Yan SX; Li HL; Liu YM; Zhan HT; Dou YL; Li YZ
    Ann Clin Microbiol Antimicrob; 2023 Nov; 22(1):102. PubMed ID: 37986091
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pneumocystis jirovecii pneumonia in children. A retrospective study in a single center over three decades.
    García-Moreno J; Melendo-Pérez S; Martín-Gómez MT; Frick MA; Balcells-Ramírez J; Pujol-Jover M; Martín-Nalda A; Mendoza-Palomar N; Soler-Palacín P
    Enferm Infecc Microbiol Clin (Engl Ed); 2020 Mar; 38(3):111-118. PubMed ID: 31272810
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Characterization and associated risk factors of Pneumocystis jirovecii pneumonia in patients with AIRD: a retrospective study.
    Zhao Z; Huang Y; Ming B; Zhong J; Dong L
    Rheumatology (Oxford); 2022 Aug; 61(9):3766-3776. PubMed ID: 34962999
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Identification of predictive markers of Pneumocystis jirovecii pneumonia in kidney transplant recipients.
    Zhou J; Pan H; Zhang J; Luo L; Cao Y; Wang L; Cheng Z; Zhang G
    Transpl Immunol; 2024 Aug; 85():102074. PubMed ID: 38945175
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The application value of metagenomic next-generation sequencing technology in diagnosis and treatment of pulmonary infection in immunocompromised patients].
    Duan ZM; Shen ZY; Hu Y; Wang KF; Fu H; Wang CL; Xie LX; Xie F
    Zhonghua Yi Xue Za Zhi; 2023 Jul; 103(25):1885-1891. PubMed ID: 37402668
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of the performance of DiaSorin molecular Pneumocystis jirovecii-CMV multiplex real-time PCR assay from bronchoalveolar lavage samples.
    Kilic A; Elliott S; Hester L; Palavecino E
    J Mycol Med; 2020 Jun; 30(2):100936. PubMed ID: 32044156
    [TBL] [Abstract][Full Text] [Related]  

  • 40. No need for secondary Pneumocystis jirovecii pneumonia prophylaxis in adult people living with HIV from Europe on ART with suppressed viraemia and a CD4 cell count greater than 100 cells/µL.
    Atkinson A; Miro JM; Mocroft A; Reiss P; Kirk O; Morlat P; Ghosn J; Stephan C; Mussini C; Antoniadou A; Doerholt K; Girardi E; De Wit S; Kraus D; Zwahlen M; Furrer H;
    J Int AIDS Soc; 2021 Jun; 24(6):e25726. PubMed ID: 34118121
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.